Do patents prevent access to drugs for HIV in developing countries?
JAMA
.
2002 Feb 20;287(7):840-1; author reply 842-3.
doi: 10.1001/jama.287.7.840.
Authors
Marleen Boelaert
,
Lut Lynen
,
Wim Van Damme
,
Robert Colebunders
PMID:
11851568
DOI:
10.1001/jama.287.7.840
No abstract available
Publication types
Comment
Letter
MeSH terms
Africa
Anti-HIV Agents / economics
Anti-HIV Agents / supply & distribution*
Developing Countries*
Drug Industry
Drugs, Generic*
Patents as Topic*
Substances
Anti-HIV Agents
Drugs, Generic